Posts in category: Uncategorized

New research from the University of Georgia suggests most people don’t understand the difference between a preprint and a published academic journal article.

Despite racial and ethnic minority groups making up nearly half of the United States population, underrepresentation in clinical trials remains a critical challenge. In an effort to improve clinical trial diversity, researchers at The Ohio State University Wexner Medical Center and College of Medicine partnered with The African American Male Wellness Agency, Genentech Inc. and Pfizer, Inc. to engage with almost 450 community members in 25 states and five countries to create solutions to barriers of access, awareness, discrimination and racism and workforce diversity.

 Yango joined the global community in celebrating International Women’s Day (IWD) on March 8th, 2023, dubbed “DigitALL: Innovation and Technology for Gender Equality”. As part of the celebration, Yango invited several female drivers for a women’s day event that took place on Wednesday 8th March, in Lusaka at The Hub. Yango Zambia Country Manager, Kabanda […]

The COVID-19 pandemic caused a disproportionate amount of illness and death among Latino families lacking permanent legal status compared with the general U.S. population—and factors such as poverty, dangerous living conditions and lack of access to health care are to blame—according to a new study from Rice University.

Anxiety and depression among school-aged children and teens in the United States are at an all-time high. Sadly, in 2021, child and adolescent mental health was declared a national emergency. Although a variety of causes are thought to contribute to this decline in mental health, a new study by three prominent researchers specializing in child development points to independent “child’s play.”

Children who experience early puberty or delayed puberty may be at risk of having shortened height as adults. They may also feel emotionally unprepared for the changes of puberty, and may feel self-conscious or experience social anxieties as a result.

Treatment is scarce for functional neurological disorder (FND), which requires a multidisciplinary approach. A special report published in the March/April issue of Harvard Review of Psychiatry (HRP) aims to show clinicians and institutions around the world what is needed to establish effective community treatment programs for FND, as well as hospital inpatient and outpatient interventions, in their own health care settings.

In the United States, managing hypertension or high blood pressure has proven to be challenging. Despite the availability of antihypertensive medications and the benefits of regular exercise, a significant number of patients continue to struggle with persistent hypertension. To tackle this issue, a new taxonomy is being developed that seeks to target the root causes of this condition.

Preliminary results from a landmark clinical trial to prevent Alzheimer’s disease (AD) symptoms show that an investigational anti-amyloid drug, solanezumab, did not demonstrate a statistically significant slowing of cognitive decline associated with AD when initiated prior to the stage of clinical impairment.

Myelodysplastic syndromes (MDS) are a diverse group of bone marrow disorders in which immature stem cells do not mature to become red blood cells, white blood cells or platelets. Patients with higher-risk MDS tend to have poorer outcomes, a greater chance of developing acute myeloid leukemia and few effective treatment options.